NCT07201857

Brief Summary

This study aims to evaluate the clinical applicability of a peri-habilitation program in patients with gastric cancer by applying nutritional intervention for approximately two weeks before surgery and a combined exercise and nutrition intervention for about three weeks after hospital discharge, and by analyzing its effects on the prevention of postoperative complications and recovery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Oct 2025Dec 2026

First Submitted

Initial submission to the registry

September 16, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 1, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

October 15, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

September 16, 2025

Last Update Submit

September 23, 2025

Conditions

Keywords

peri-habilitationgastric cancerpostoperative recoveryexercise intervention

Outcome Measures

Primary Outcomes (4)

  • Gait speed test

    * Time to walk 4 meters (or 3 meters) at a normal, comfortable pace. * Seconds(sec) * Lower values(seconds) indicate better performance (faster walking speed)

    Baseline (2 weeks before surgery) Preoperative hospitalization (1-4 days before surgery) Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

  • Chair stand test

    * Time to stand up and sit down 5 times from a chair without using the arms. * Seconds(sec) * Lower values(seconds) indicate better performance.

    Baseline (2 weeks before surgery) Preoperative hospitalization (1-4 days before surgery) Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

  • Balance test

    * Time maintaining balance in three positions (feet together, semi-tandem, and tandem stance). The maximum time allowed for each position is 10 seconds. * Seconds(sec) * Higher values(seconds) indicate better performance.

    Baseline (2 weeks before surgery) Preoperative hospitalization (1-4 days before surgery) Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

  • Timed up and go test

    * Time to stand up from a chair, walk 3 meters, turn around, walk back, and sit down. * Seconds(sec) * Lower values(seconds) indicate better performance.

    Baseline (2 weeks before surgery) Preoperative hospitalization (1-4 days before surgery) Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

Secondary Outcomes (5)

  • Electrocardiogram(ECG)

    Baseline (2 weeks before surgery) Preoperative hospitalization (1-4 days before surgery) Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

  • Inflammation and Oxidative Stress Markers (Blood Analysis)

    Baseline (2 weeks before surgery) Preoperative hospitalization (1-4 days before surgery) Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

  • Hospital Anxiety and Depression Scale (HADS)

    Baseline (2 weeks before surgery) Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

  • Quality of life(KOQUSS-32, KOQUSS-40)

    Baseline (2 weeks before surgery) 3 weeks after discharge 6 months after surgery

  • Clavien-dindo classification

    Postoperative discharge (at hospital discharge) 3 weeks after discharge 6 months after surgery

Study Arms (2)

Nutrition (NUT)

ACTIVE COMPARATOR

Nutrition (NUT) Participants will receive standard clinical care combined with nutrition education and protein-enriched soy milk supplementation for approximately 2 weeks before surgery and about 3 weeks after hospital discharge.

Dietary Supplement: nutrition education plus active supplement

Exercise and Nutrition(EN)

EXPERIMENTAL

Exercise and Nutrition Group (EN) Participants will receive peri-habilitation exercise training in combination with nutritional intervention, including carbohydrate plus protein-enriched soy milk supplementation twice daily (before and after exercise), for approximately 2 weeks before surgery and about 3 weeks after hospital discharge.

Behavioral: Exercise

Interventions

Nutrition Group (NUT) Participants will receive standard clinical care combined with nutrition education and protein-enriched soy milk supplementation for approximately 2 weeks before surgery and about 3 weeks after hospital discharge.

Also known as: Nutrition
Nutrition (NUT)
ExerciseBEHAVIORAL

Exercise and Nutrition Participants will receive peri-habilitation exercise training together with nutritional intervention, including carbohydrate plus protein-enriched soy milk supplementation twice daily (before and after exercise), for approximately 2 weeks before surgery and about 3 weeks after hospital discharge.

Also known as: Exercise and Nutrition
Exercise and Nutrition(EN)

Eligibility Criteria

Age65 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients aged 65 years or older who have been diagnosed with gastric cancer and are scheduled to undergo surgical treatment or chemotherapy.

You may not qualify if:

  • Patients with severe conditions who are unable to undergo the intervention prior to surgical treatment or chemotherapy.
  • Patients with physical (e.g., musculoskeletal) or mental disorders that make participation in or continuation of the program impossible.
  • Patients judged to be at risk of additional physical burden from the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anam Hospital

Seoul, seongbuk-gu, 02841, South Korea

Location

MeSH Terms

Conditions

Stomach NeoplasmsDisease

Interventions

Nutrition AssessmentNutritional StatusExercise

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemographyPopulation CharacteristicsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Surgery

Study Record Dates

First Submitted

September 16, 2025

First Posted

October 1, 2025

Study Start

October 15, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

October 1, 2025

Record last verified: 2025-09

Locations